Glaukos Corp
glaukos.comGlaukos Corporation (NYSE: GKOS) is a ophthalmic medical device company that develops and commercializes surgical and pharmaceutical products targeting glaucoma and corneal health conditions. The company generates revenue primarily through the sale of its micro-invasive glaucoma surgery (MIGS) devices and corneal health products to hospitals, ambulatory surgery centers, and eye care professionals. The 10-K filed 2026-02-23 (accession 000119312526061944) covers the fiscal year ended in that cycle, but the filing excerpts provided contain only the cover page and do not disclose segment revenue breakdowns, customer concentration figures, geographic mix, or named competitors. Based solely on the available filing content, Glaukos is incorporated and operates as a publicly traded U.S. medical device company listed on a national exchange under the ticker GKOS, focused on ophthalmic conditions.
Products & Services
The filing excerpts do not enumerate specific products or brands beyond the company's general focus on glaucoma and corneal health surgical devices.
Revenue Model
The filing excerpts provided do not contain sufficient detail to describe the revenue model beyond that Glaukos sells ophthalmic medical devices and related products. No pricing model, segment percentages, or unit economics are disclosed in the available excerpts.
Customers & Markets
The filing excerpts do not identify specific customers, customer concentration figures, or end market details.
Geographic Exposure
The filing excerpts do not disclose geographic revenue breakdown or operational footprint details.
Financial Snapshot
Loading...
